INSIDE PHARMA develops and grows value delivered to its subscribers
A new phase of laser focus begins...
SARS-CoV-2 injections landscape changes
Since INSIDE PHARMA first launched in January 2022, the SARS-CoV-2 injections landscape has changed significantly; at least, so it seems to me.
At that time, censorship of REAL experts was rife, misinformation was being peddled through every conceivable channel, and there seemed to be no way forward to penetrate the lies and fabrications of Big Pharma, Big Corporations, and Big Tech.
We are still not out of the woods, of course. However, with the release of the Pfizer documents courtesy of a sympathetic judge (his special place is reserved in heaven!), Senator Rand Paul and others publically knocking lumps out of Fauci. Elon Musk buying Twitter, with #BillGatesIsEvil trending regularly, and Brook Jackson, Sasha Latypova, PJH Law, and many others putting their shoulder to the wheel, surely there is room for optimism?
Along with optimism now, me thinks, must follow laser focus on the issues that are going to bring the evil scheming slugs down to earth. That is why I have revisited INSIDE PHARMA’s mission going forward, to:
INSIDE PHARMA - Sharing totally unique insights on the pharma industry, along with practical ways to reform it, based on indisputable facts, evidence and education.
The ABOUT page is also revisited, as so:
INSIDE PHARMA—what’s in it for you?
‘YOU’ will be a critical thinker on the medicines, medical devices, diagnostic tests, and any other allegedly therapeutic products, that you, your loved ones, friends and colleagues may be offered or exposed to.
Critical thinking means unfettered access to facts, evidence and deep, inside knowledge. MSN fed propaganda is not what you are looking for—you want to hear the truth, and that’s what you will get here.
Who is behind it?
It’s me, Hedley Rees.
During August 2021, I was expelled from LinkedIn, where I had been well regarded as the voice of radical change for the pharma industry. Open minded people there valued my vision of an industry where patients and healthcare professionals were central to medical progress. The ones that didn’t orchestrated my permanent removal.
My bio reads like this:
Hedley Rees is the Managing Consultant at PharmaFlow Limited (2005), a UK based consultancy specializing in operations and supply chain management within the pharmaceutical and life science sectors.
Clients range from large pharmaceutical companies to emerging biotech, and also include investors, lawyers, other consultancies, facility design & build specialists and third-party logistics providers (3PLs).
Assignments span preclinical, clinical, and commercial supply chains up to complex multi-product networks covering global territories.
Qualifications: B. Eng. (Tech) Hons Production Engineering, University of Wales; Executive MBA, Cranfield University School of Management.
Previous Appointments: Senior positions at Bayer UK, British Biotech, Vernalis, Ortho-Clinical Diagnostics and OSI Pharmaceuticals (now Astellas).
Affiliations and qualifications:
Author, Supply Chain Management in the Drug Industry: Delivering Patient Value forPharmaceuticals and Biologics, Wiley, 2011
Advisory Board Member, International Institute, Advanced Purchasing & Supply (IIAPS).
Editorial Board Member and contributor, GMP Review (GMP = Good Manufacturing Practice).
Former consultant to Oxford BioMedica on UK Government funding call AdvancedManufacturing Supply Chain Initiative (AMSCI), resulting in funding of £7.1M
Former Advisory Board Member to Marken, 2011 - 2012 (now a UPS company).
Founding Member of Expert Industry Panel for CPhI Worldwide (UBM plc)
Former member of the UK Bio-Industry Association’s (BIA) Manufacturing Advisory Committee, 2007 – 2011
What will INSIDE PHARMA give you access to?
Hedley’s 40+ years experience working in the industry as a consultant and leader in drug development and commercial supply chains, including vaccines.
Easy to understand virtual learning on industry fundamentals, based on Hedley’s progamme for the University of South Wales School of Applied Sciences, titled The Pharmaceutical Industry and Evidence-Based Healthcare, described in this introductory video
Interviews with hand-picked experts from Hedley’s vast network of contacts who are working diligently to course-correct the downward spiral that is the Big Pharma modus operandi. Brook Jackson and Sasha Latypova are examples.
And much more - check out the archives to fill your boots with the possibilities!
What else is being revisited?
I have become a pharma outcast, who wasn’t very popular in the first place with the greedy inhabitants remaining (former clients), who prefer to cut corners and twist the truth. I’ve therefore switched on paid subscriptions in the last few weeks.
The increased focus above aims to deliver value that far exceeds the monthly subscription of $5 (minimum Substack allows).
Cheers for now, Hedley
Dear Phil,
Thank you so much for the feedback, very helpful. I am in agreement with much of what you say. The fear and confusion created by COVID malpractices and Mr. global activities has created a giant appetite for 'the truth'. Many are taking advantage of the opportunity to generate revenues that they otherwise would not have been able to derive absent fear and confusion.
Turning to your comment below:
"Original content being the Holy Grail of news outlets requires an expensive network of "boots on the ground" reporters which most news sites cannot afford; hence, many scour other sites for content to place on their own website to monetize by simply clicking their laptop. This is a common and legitimate practice but readers should not be fooled into paying for news that can be read for free. Could this be the business model you intend to pursue on your substack blog?"
This is valuable information for me, as I believed I'd shared enough on my background and motivations to convince potential paid subscribers of INSIDE PHARMAs unique offering. You seem to have me in the 'let's regurgitate any old news' camp, which is definitely not where I am....but that is for you to judge.
I should also mention that I am doing a tremendous amount of work for free. My Expert Witness Report for PJH Law has gone to Dr Mike Yeadon, Reiner Fuellmich, Robert Kennedy Jr, ICAN, etc etc. I've sought no recompense in return, and none has been offered. Here it is: https://www.dropbox.com/s/30r8p7e86hkga71/Hedley%20Expert%20report_17122021.pdf?dl=0 You should see from that the unique offering I am providing...but that is for you to judge.
The approach I am taking now gives people a choice as to whether they want more than news - that is insights, they won't get anywhere else - or not. Paid subscriptions can be cancelled at will, and there is enough of a track record of free posts to tell peeps what they can expect.
It is highly likely very few will take up the paid route, for the reasons you state, but I must give it a try.
Thanks again Phil for such a frank comment. Best, Hedley
June 23, 2022
Dear Mr. Rees,
The alternative media is strewn with peddlers of the truth, replete with solicitations for donations on their sites, yet much of their content may be read for free or obtained elsewhere. With diligence, persistence and creativity one may glean enough information to assemble a modicum of truth about any current topic by searching these multiple sources for a viable sense of the truth, which should be the preferred method for seeking truth in the first place.
No one site can claim ownership of the whole truth and it is irksome to find aggregators of news erect a paywall on a story they most likely plagiarized from any number of other sites none of whom actually originated the story themselves. I guess they take us for fools. This parallels the pattern that bots take when one sees the exact same headline on dozens of sites pretending to be breaking news.
Original content being the Holy Grail of news outlets requires an expensive network of "boots on the ground" reporters which most news sites cannot afford; hence, many scour other sites for content to place on their own website to monetize by simply clicking their laptop. This is a common and legitimate practice but readers should not be fooled into paying for news that can be read for free. Could this be the business model you intend to pursue on your substack blog?
Your webpage presents a very convincing argument that it will feature quality content by experts in their respective fields which cannot be obtained from any MSM. That should be a given but why should readers pony up their hard earned money without seeing proof of that beforehand?
If you were willing to offer a one month free subscription, no strings attached & no credit card information required for readers to evaluate whether or not a free trial subscription is justified, I would happily agree. And if, after 30 days, I decide it is not, then you have every right to block me from receiving any further content and I go on my merry way.
With paywalls having been erected on almost every news site including MSM these days, it becomes a question for subscribers of how to narrow down which one(s) will provide the most comprehensive coverage that is of interest to them. The fact is, if one cares to follow the aforementioned formula that multiple sources are required for any semblance of the truth then it becomes a matter of finances. How much can one afford? For many, like me, not much.
The NYT may soon eliminate print editions of their newspaper which would be traumatic for those who like the feel of something in their hands when when reading yesterdays news.
So far, this trend for digital on line reading has not significantly impacted the book selling business and, as a former book dealer, I am thankful for that; however, the book reading universe is on a course to be a totally digital experience which would not only be a loss for avid book collectors & readers like myself, but also pulp mills and timber companies, not to mention printers & publishers.
I hope I have made my point Mr. Rees and hope I get a response of some kind soon. In the meantime, I wish you luck barking in a lot of new customers. Until then I give you my..
Finest regards,
desertmonkey
Tucson, AZ